Skip to main content

Former Practice Fusion CEO’s second act is going to market, backed by major life insurers

The San Francisco-based company sells a smartwatch launching in July that monitors biomarkers like a user’s heart rate, pulse strength, temperature, blood flow, oxygen levels to look for signals indicating a life-threatening cardiac episode and automatically alert emergency authorities.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.